v3.25.4
Equity Awards (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Information About Outstanding And Vested Stock Options
A summary of stock option activity for the year ended December 31, 2025 was as follows:
Number of
Shares
(in thousands)
Weighted-
Average
Exercise
Price Per
Share
Weighted-
Average
Remaining
Contractual
Term
(in years)
Aggregate
Intrinsic
Value
(in millions)
Outstanding as of December 31, 20244,739 $123.88 
Granted (1)
426 $20.34 
Exercised(179)$116.60 $12 
Forfeited(157)$131.10 
Outstanding as of December 31, 20254,829 $114.78 5.8$185 
Vested and expected to vest as of December 31, 20254,671 $114.95 5.8$179 
Vested and exercisable as of December 31, 20252,550 $113.87 5.3$100 
(1)Relates to stock options assumed in business combinations.
Restricted Stock Unit Table
A summary of RSU activity for the year ended December 31, 2025 was as follows:
Number of
Shares
Weighted-
Average
Grant-Date
Fair Value Per
Share
 
(in thousands)
Outstanding as of December 31, 202428,940 $126.02 
Granted14,486 $190.71 
Vested(14,136)$128.51 
Forfeited(3,279)$143.17 
Outstanding as of December 31, 202526,011 $158.53 
Expected to vest as of December 31, 202523,500 
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
The following assumptions were used in the Black-Scholes options pricing model and the Monte Carlo simulation model, to estimate our stock-based compensation on the date of grant for ESPP, stock options and PRSUs, respectively, as applicable.
 Year Ended December 31,
202520242023
Risk-Free Interest Rate
ESPP
4.08% - 4.96%
4.96% - 5.39%
2.96% - 5.39%
Stock Options
3.80% - 4.07%
**
PRSU
4.18% - 4.24%
3.97% - 4.56%
4.34%
Expected Term (in years)
ESPP0.50.50.5
Stock Options
6.0 - 9.0
**
Expected Volatility
ESPP
32% - 45%
25% - 40%
33% - 59%
Stock Options
39% - 42%
**
PRSU
33% - 40%
33% - 42%
45%
* There were no stock option grants in 2024 and 2023.